Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Surgery & combination therapy optimises results in aggressive prostate cancer management

Surgery & combination therapy optimises results in aggressive prostate cancer management

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'

Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'

Hormone-blocking injections reduce early menopause from breast cancer treatment

Hormone-blocking injections reduce early menopause from breast cancer treatment

ESMO 2018: Zoledronic acid improves disease-free survival in premenopausal HR early breast cancer

ESMO 2018: Zoledronic acid improves disease-free survival in premenopausal HR early breast cancer

ESMO 2018: Some patients with metastatic triple negative breast cancer live longer with immunotherapy

ESMO 2018: Some patients with metastatic triple negative breast cancer live longer with immunotherapy

ESMO 2018: New option for women with advanced breast cancer resistant to hormone therapy

ESMO 2018: New option for women with advanced breast cancer resistant to hormone therapy

ESMO 2018: Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

ESMO 2018: Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

Immune cells in triple-negative breast cancer offer potential therapeutic target

Immune cells in triple-negative breast cancer offer potential therapeutic target

More from ecancer